KR20010013332A - 바쿨로바이러스 발현 시스템에서 생성된 레트로바이러스성벡터 입자 - Google Patents

바쿨로바이러스 발현 시스템에서 생성된 레트로바이러스성벡터 입자 Download PDF

Info

Publication number
KR20010013332A
KR20010013332A KR19997011328A KR19997011328A KR20010013332A KR 20010013332 A KR20010013332 A KR 20010013332A KR 19997011328 A KR19997011328 A KR 19997011328A KR 19997011328 A KR19997011328 A KR 19997011328A KR 20010013332 A KR20010013332 A KR 20010013332A
Authority
KR
South Korea
Prior art keywords
composition
component
retroviral
promoter
baculovirus
Prior art date
Application number
KR19997011328A
Other languages
English (en)
French (fr)
Korean (ko)
Inventor
킹스만알란존
존스이안마틴
Original Assignee
찰스 굿맨
옥스포드 바이오메디카(유케이) 리미티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 찰스 굿맨, 옥스포드 바이오메디카(유케이) 리미티드 filed Critical 찰스 굿맨
Publication of KR20010013332A publication Critical patent/KR20010013332A/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/14011—Baculoviridae
    • C12N2710/14111—Nucleopolyhedrovirus, e.g. autographa californica nucleopolyhedrovirus
    • C12N2710/14141—Use of virus, viral particle or viral elements as a vector
    • C12N2710/14144—Chimeric viral vector comprising heterologous viral elements for production of another viral vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
    • C12N2740/13041—Use of virus, viral particle or viral elements as a vector
    • C12N2740/13043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
    • C12N2740/13051—Methods of production or purification of viral material
    • C12N2740/13052—Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
    • C12N2740/15041—Use of virus, viral particle or viral elements as a vector
    • C12N2740/15043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
    • C12N2740/15051—Methods of production or purification of viral material
    • C12N2740/15052—Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles
KR19997011328A 1997-06-04 1998-06-04 바쿨로바이러스 발현 시스템에서 생성된 레트로바이러스성벡터 입자 KR20010013332A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9711578.6 1997-06-04
GBGB9711578.6A GB9711578D0 (en) 1997-06-04 1997-06-04 Novel retroviral vector production systems
PCT/GB1998/001626 WO1998055640A1 (en) 1997-06-04 1998-06-04 Retroviral vector particles produced in a baculovirus expression system

Publications (1)

Publication Number Publication Date
KR20010013332A true KR20010013332A (ko) 2001-02-26

Family

ID=10813571

Family Applications (1)

Application Number Title Priority Date Filing Date
KR19997011328A KR20010013332A (ko) 1997-06-04 1998-06-04 바쿨로바이러스 발현 시스템에서 생성된 레트로바이러스성벡터 입자

Country Status (11)

Country Link
EP (1) EP0986649A1 (ja)
JP (1) JP2002510204A (ja)
KR (1) KR20010013332A (ja)
CN (1) CN1259171A (ja)
AU (1) AU741764B2 (ja)
CA (1) CA2289491A1 (ja)
GB (1) GB9711578D0 (ja)
IL (1) IL132359A0 (ja)
NO (1) NO995900L (ja)
NZ (1) NZ500936A (ja)
WO (1) WO1998055640A1 (ja)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5448400A (en) * 1999-05-28 2000-12-18 Mount Sinai School Of Medicine, The A novel baculovirus/adenovirus hybrid vector for the rescue, production and titration of high-capacity adenovirus amplicon vectors
AU3054502A (en) 2000-10-23 2002-05-06 Gen Probe Inc Compositions and methods for detecting human immunodeficiency virus 2 (hiv-2)
TWI477602B (zh) 2006-02-09 2015-03-21 Educational Foundation Jichi Medical Univ Novel viral vector
US9333249B2 (en) 2006-02-09 2016-05-10 Educational Foundation Jichi Medical University Recombinant baculovirus vaccine
GB0702695D0 (en) * 2007-02-12 2007-03-21 Ark Therapeutics Ltd Production of vectors
JP5309159B2 (ja) * 2008-01-09 2013-10-09 コングク ユニバーシティ インダストリアル コーオペレーション コーポレーション バキュロウイルスを利用したワクチン

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1309680C (en) * 1987-07-24 1992-11-03 David Harano Airlift insect cell culture
WO1989009271A1 (en) * 1988-03-21 1989-10-05 Viagene, Inc. Recombinant retroviruses
WO1991019803A1 (en) * 1990-06-19 1991-12-26 Applied Biotechnology, Incorporated Self assembled, defective, nonself-propagating viral particles
GB9510272D0 (en) * 1995-05-22 1995-07-19 Isis Innovation Retroviral vectors

Also Published As

Publication number Publication date
CN1259171A (zh) 2000-07-05
GB9711578D0 (en) 1997-07-30
NO995900L (no) 2000-02-04
AU7780098A (en) 1998-12-21
EP0986649A1 (en) 2000-03-22
AU741764B2 (en) 2001-12-06
WO1998055640A1 (en) 1998-12-10
JP2002510204A (ja) 2002-04-02
CA2289491A1 (en) 1998-12-10
IL132359A0 (en) 2001-03-19
NZ500936A (en) 2001-11-30
NO995900D0 (no) 1999-12-02

Similar Documents

Publication Publication Date Title
US7419829B2 (en) Vector system
JP4640742B2 (ja) 高力価で安全な組換えレンチウイルスベクター作成の方法及び手段
US20090111106A1 (en) Vector System
EP1080216B1 (en) Retroviral delivery system
JP2001517452A (ja) 機能的スプライス・ドナー部位及び機能的スプライス・アクセプター部位を含むレトロウイルスベクター
JP2002538829A (ja) 抗ウイルスベクター
US6818209B1 (en) Retroviral delivery system
AU1395400A (en) Vector
JP2019514414A (ja) ゲノム工学システムのカプシド形成のための粒子
US9932597B2 (en) Vectors for transgene expression
AU4642297A (en) Alphavirus-retrovirus vectors
WO1998015636A9 (en) Alphavirus-retrovirus vectors
AU741764B2 (en) Retroviral vector particles produced in a baculovirus expression system
WO1995019368A1 (en) Retroviral vector particles for transducing non-proliferating cells
JP2002539797A (ja) 機能的および非機能的なスプライス供与部位ならびにスプライス受容部位を含むレトロウイルスベクター
JP2003501070A (ja) 阻害性ＲＮＡ分子を決定するためのｉｎｖｉｖｏでの選択方法
US20230151388A1 (en) Modified vectors for production of retrovirus
JP2003500061A (ja) 改善されたレトロウイルスの産生
GB2337520A (en) Retroviral delivery system

Legal Events

Date Code Title Description
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid